Brookdale's primary and secondary service areas together comprise 1 million residents. It serves most of Eastern Brooklyn: Brownsville, East New York, Canarsie and East Flatbush.In 2017, it was described as "struggling." In 2009 they had 'let go' 240 employees.
BACKGROUND:Establishing a comprehensive apheresis medicine program in a resource-constrained setting presents significant structural, financial, and logistical challenges. Despite the growing clinical importance of apheresis services globally, published experience from sub-Saharan Africa remains sparse. This study describes the 5-year operational experience of building and sustaining an Apheresis Medicine program at Next Hematology Medicare, a private hematology center in Lagos, Nigeria, including the challenges encountered, solutions implemented, and clinical outcomes achieved. METHODS:A retrospective review of all apheresis procedures performed between May 2020 and December 2025 was conducted. Therapeutic apheresis procedures included automated red cell exchange transfusion (RCE), therapeutic plasma exchange (TPE) and leukocytapheresis. Donor apheresis procedures comprised single-donor apheresis platelet collections for transfusion and stem cell collection (SCC) by donors. Data on patient demographics, clinical indications, procedural outcomes, and geographic distribution of platelet delivery were collected and analyzed. RESULTS:A total of 2405 apheresis procedures were performed over the 5-year period. Donor apheresis platelet (AP) collection was the most frequently performed procedure (n = 1772; 73.7%), followed by RCE (n = 617; 25.7%) as the most common therapeutic apheresis modality. TPE accounted for 12 procedures (n = 12; 0.5%), while leukocytapheresis (n = 2; < 0.1%) and SCC (n = 1; < 0.1%) were performed infrequently. For AP, Sepsis/DIC was the leading transfusion indication (n = 968; 54.6%). RCE was performed predominantly for patients with sickle cell anemia (SCA), with intractable recurrent vaso-occlusive crises (VOC) being the most common indication (n = 382; 61.9%). RCE significantly reduced hemoglobin S (HbS%) from 93.13% ± 12.4% to 18.74% ± 4.2% (p < 0.001) and improved hematocrit from 16.34% ± 3.5% to 26.01% ± 4.2% (p < 0.001). TPE was primarily indicated for neurological and transplant-related conditions. Apheresis platelets were distributed nationally across all six geopolitical zones and internationally. CONCLUSION:A fully functional Apheresis Medicine program can be successfully established and sustained in a resource-constrained low- and middle-income country (LMIC) setting, delivering outcomes comparable to high-income country benchmarks. RCE showed significant hematological benefits for patients with SCA, and donor apheresis platelet delivery extended care across all Nigerian geopolitical zones. The operational framework described here, addressing funding, infrastructure, staffing, licensing, and blood safety, provides a possibly replicable model for Apheresis Medicine program development across sub-Saharan Africa.
INTRODUCTION: Metabolic dysfunction-associated steatotic liver disease (MASLD) represents a significant contributor to morbidity and mortality, linked to adverse cardiovascular outcomes. While extensive research highlights the cardiovascular burden in non-lean MASLD, lean MASLD remains comparatively understudied. To address this gap, our study evaluates cardiovascular outcomes in lean MASLD compared with non-lean MASLD. METHODS: This is a retrospective cohort study of patients with MASLD identified in the multi-institutional database, TriNetX. Lean MASLD was defined as a body mass index <25 kg/m2. Leveraging 1:1 propensity score matching, we balanced baseline characteristics, including age, sex, comorbidities, laboratory values, and medication use. Cox proportional hazards models were used to calculate hazard ratios (HRs) with 95% confidence intervals (CIs) for cardiovascular events, cerebrovascular outcomes, new-onset heart failure, and all-cause mortality over 1-, 3-, 5-, and 7-year follow-up. RESULTS: After matching, there were 67,519 patients in both groups. At 7-year follow-up, lean patients with MASLD demonstrated significantly higher rates of new onset heart failure compared with non-lean patients with MASLD (HR: 1.23, 95% CI: 1.16-1.31, P < 0.0001), composite cardiovascular events (HR: 1.21, 95% CI: 1.13-1.30, P < 0.0001), cerebrovascular events (HR: 1.33, 95% CI: 1.24-1.43, P < 0.0001), and all-cause mortality (HR: 1.48, 95% CI: 1.38-1.59, P < 0.0001). These increased risks were noted at 1-, 3-, and 5-year follow-up. DISCUSSION: Patients with lean MASLD are at significantly higher risks of cardiovascular events and all-cause mortality compared with non-lean patients with MASLD. Further research is needed to clarify the underlying pathophysiology and develop tailored interventions to improve outcomes for this growing population.
IntroductionOver four years have passed since the World Health Organization (WHO) declared COVID-19 a pandemic. During the early phase of the pandemic (approximately March 2020 to June 2021), effective therapeutics and vaccines were not available. Many countries implemented societal infection control measures to curb the spread of the virus. The United States and Sweden adopted markedly different public health strategies. The United States declared a national emergency and implemented strict measures, including lockdowns and school closures, whereas Sweden relied largely on voluntary guidelines without mandating extensive societal controls. Understanding how these divergent approaches affected the mental health of children and adolescents during this critical initial period can inform future health policies and interventions. This scoping review aimed to examine how COVID-19 and associated public health measures impacted the mental health of children and adolescents in the United States and Sweden during the early phase of the pandemic (March 2020 to June 2021). MethodsWe carried out a scoping review following PRISMA-ScR guidelines. English-language, peer-reviewed articles published between January 2020 and June 2022 were identified in MEDLINE, PubMed, Google Scholar, MedRxiv, PsyArXiv, and WHO Global Literature on coronavirus disease. Studies focusing on mental health outcomes in U.S. and Swedish youth (ages 3–24) during the early phase of the pandemic were included. Data extraction and quality appraisal followed Joanna Briggs Institute guidelines. ResultsOf 1,596 references screened, 32 studies (22 from the U.S. and 10 from Sweden) met inclusion criteria, involving a combined 776,586 participants. The majority were cross-sectional studies. U.S. data indicated a deterioration in mental health due to stringent infection control measures, school closures, and social isolation, affecting the well-being of children and adolescents and increasing symptoms of anxiety, depression, and loneliness. In contrast, Sweden’s decision to keep primary schools open preserved a sense of normalcy, contributing to comparatively stable mental health outcomes with fewer signs of increased distress. DiscussionDuring the early pandemic phase, U.S. children and adolescents experienced worsening mental health as lockdowns persisted, while Swedish youth showed fewer adverse changes. Factors, such as developmental stage, socioeconomic status, and access to supportive services, influenced outcomes. This scoping review underscores the need for balanced public health policies that mitigate infection risks while supporting the mental health and well-being of young populations. ConclusionThe early phase of the COVID-19 pandemic had significant but variable mental health effects on children and adolescents. Stringent restrictions in the U.S. correlated with increased psychological distress, whereas Sweden’s less disruptive approach may have helped maintain better well-being. Understanding these early responses can inform future strategies for addressing the mental health needs of youth during global crises.
Background:Endoscopic sleeve gastroplasty (ESG) facilitates 13.6%-16.2% total body weight loss (TBWL) at 12 months, but falls short of that seen with surgical vertical sleeve gastrectomy, in part owing to the retention of the gastric fundus. In adults with obesity, gastric fundal mucosal ablation (GFMA) reduces fasting plasma ghrelin (FPG), hunger, cravings, and accommodation. Combined GFMA-ESG could improve TBWL. This study aimed to evaluate the effectiveness and safety of sequential GFMA followed by ESG in adults with obesity, building on previously published 6-month results of GFMA alone. Methods:This was a prospective, first-in-human, two-phase clinical trial. Ten participants underwent GFMA, followed by ESG at month 6, and were followed for 12 months post-ESG (18 months total). GFMA was performed using hybrid argon plasma coagulation to lift and ablate the entire gastric fundal mucosa. ESG was performed using standard full-thickness endoscopic suturing of the gastric body. The primary end point was TBWL; secondary end points were safety and changes in FPG, maximum tolerated volume (MTV), and validated appetite questionnaires. Results:Mean TBWL was 22.5% (SD 8.3%) at month 18. Hunger-related behaviors and eating self-efficacy showed sustained improvements. FPG was decreased at month 6 and returned toward baseline by month 18, while MTV remained suppressed. No serious adverse events occurred. Conclusions:Sequential GFMA-ESG is safe and induces substantial weight loss, reduced MTV of ingested nutrients, and improved behavioral measures. This combination approach builds on prior traditional ESG and GFMA-only results and may represent a promising advancement of endoscopic therapeutic options for weight loss.
We examined developmental trajectories of receptive and expressive language abilities in children aged 1 to 5 years and beyond. We retrospectively recruited 158 children. Using the Sequenced Language Scale for Infants and the Preschool Receptive-Expressive Language Scale, children were grouped as typically developing (TD), mildly delayed (MD), or severely delayed (SD). Language was assessed under 3 age groups: under 2 years, 2 to <5 years (in 6-month intervals), and ≥5 years. Most TD children before age 5 remained TD, although some transitioned to MD or SD, especially after 3.5 years. The MD children at younger ages often improved to TD, but this likelihood declined approaching age 5. Those classified as SD had a lower chance of improvement, with fewer transitioning to MD or TD. The likelihood of improvement from MD and SD decreased with age. Children exhibiting both MD and SD demonstrate potential for improvement; however, the likelihood decreases with age.